We use cookies and other similar technologies (Cookies) to enhance your experience and to provide you with relevant content and ads. By using our website, you are agreeing to the use of Cookies. You can change your settings at any time. Cookie Policy.

ABIOMED Selects Answerthink and SAP

Originally published February 17, 2006

Answerthink, recently announced that it has been selected by ABIOMED, for the purchase, implementation, and support of EzLifeSciences, a mySAP All-in-One solution designed to streamline business processes and position the company for continued growth.

ABIOMED, is a developer, manufacturer and marketer of circulatory support technology for patients in heart failure. ABIOMED is currently the only company with FDA labeling on ventricular assist devices for all potentially recoverable acute heart failure indications. To date, more than 8,000 patients worldwide have been supported with ABIOMED devices including the AB5000 Circulatory Support System and the BVS 5000 Biventricular Support System. The company chose Answerthink based on the strength of its life sciences experience and its preconfigured solution built on the industry-leading mySAP software.

EzLifeSciences is an industry-specific offering from Answerthink based on best practices from SAP and customized for companies in the pharmaceutical and life sciences industries. It provides the benefits of a fixed-price, fixed-scope, fixed-timeline offering that is designed specifically to help life sciences companies achieve goals such as streamline new product development and automate processes required for FDA approvals and regulatory compliance.

"We selected Answerthink and SAP in part because we liked Answerthink's business process focused methodology," said Daniel Lubin, Director of IT for ABIOMED. "Utilizing SAP to implement best practices, ABIOMED will obtain a fully validated system that is up and running faster, to enable powerful visibility into the critical operations of the business and enhance our business decision support capabilities."

This BeyeNETWORK news item contains information from a recent press release by the company mentioned.